Literature DB >> 26791950

Quantifying prion disease penetrance using large population control cohorts.

Eric Vallabh Minikel1, Sonia M Vallabh2, Monkol Lek3, Karol Estrada3, Kaitlin E Samocha4, J Fah Sathirapongsasuti5, Cory Y McLean5, Joyce Y Tung5, Linda P C Yu5, Pierluigi Gambetti6, Janis Blevins6, Shulin Zhang7, Yvonne Cohen6, Wei Chen6, Masahito Yamada8, Tsuyoshi Hamaguchi8, Nobuo Sanjo9, Hidehiro Mizusawa10, Yosikazu Nakamura11, Tetsuyuki Kitamoto12, Steven J Collins13, Alison Boyd13, Robert G Will14, Richard Knight14, Claudia Ponto15, Inga Zerr15, Theo F J Kraus16, Sabina Eigenbrod16, Armin Giese16, Miguel Calero17, Jesús de Pedro-Cuesta17, Stéphane Haïk18, Jean-Louis Laplanche19, Elodie Bouaziz-Amar19, Jean-Philippe Brandel18, Sabina Capellari20, Piero Parchi20, Anna Poleggi21, Anna Ladogana21, Anne H O'Donnell-Luria22, Konrad J Karczewski3, Jamie L Marshall3, Michael Boehnke23, Markku Laakso24, Karen L Mohlke25, Anna Kähler26, Kimberly Chambert27, Steven McCarroll27, Patrick F Sullivan28, Christina M Hultman26, Shaun M Purcell29, Pamela Sklar29, Sven J van der Lee30, Annemieke Rozemuller31, Casper Jansen31, Albert Hofman30, Robert Kraaij32, Jeroen G J van Rooij32, M Arfan Ikram30, André G Uitterlinden33, Cornelia M van Duijn30, Mark J Daly3, Daniel G MacArthur34.   

Abstract

More than 100,000 genetic variants are reported to cause Mendelian disease in humans, but the penetrance-the probability that a carrier of the purported disease-causing genotype will indeed develop the disease-is generally unknown. We assess the impact of variants in the prion protein gene (PRNP) on the risk of prion disease by analyzing 16,025 prion disease cases, 60,706 population control exomes, and 531,575 individuals genotyped by 23andMe Inc. We show that missense variants in PRNP previously reported to be pathogenic are at least 30 times more common in the population than expected on the basis of genetic prion disease prevalence. Although some of this excess can be attributed to benign variants falsely assigned as pathogenic, other variants have genuine effects on disease susceptibility but confer lifetime risks ranging from <0.1 to ~100%. We also show that truncating variants in PRNP have position-dependent effects, with true loss-of-function alleles found in healthy older individuals, a finding that supports the safety of therapeutic suppression of prion protein expression.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26791950      PMCID: PMC4774245          DOI: 10.1126/scitranslmed.aad5169

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  97 in total

1.  Spontaneous generation of anchorless prions in transgenic mice.

Authors:  Jan Stöhr; Joel C Watts; Giuseppe Legname; Abby Oehler; Azucena Lemus; Hoang-Oanh B Nguyen; Joshua Sussman; Holger Wille; Stephen J DeArmond; Stanley B Prusiner; Kurt Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178.

Authors:  R Medori; P Montagna; H J Tritschler; A LeBlanc; P Cortelli; P Tinuper; E Lugaresi; P Gambetti
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

3.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

4.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

5.  Huntington disease phenocopy is a familial prion disease.

Authors:  R C Moore; F Xiang; J Monaghan; D Han; Z Zhang; L Edström; M Anvret; S B Prusiner
Journal:  Am J Hum Genet       Date:  2001-10-09       Impact factor: 11.025

6.  PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit.

Authors:  Jon A Beck; Mark Poulter; Tracy A Campbell; Gary Adamson; James B Uphill; Rita Guerreiro; Graham S Jackson; James C Stevens; Hadi Manji; John Collinge; Simon Mead
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

7.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

8.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

9.  On the use of familial aggregation in population-based case probands for calculating penetrance.

Authors:  Colin B Begg
Journal:  J Natl Cancer Inst       Date:  2002-08-21       Impact factor: 13.506

10.  Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice.

Authors:  Karah Nazor Friberg; Gene Hung; Ed Wancewicz; Kurt Giles; Chris Black; Sue Freier; Frank Bennett; Stephen J Dearmond; Yevgeniy Freyman; Pierre Lessard; Sina Ghaemmaghami; Stanley B Prusiner
Journal:  Mol Ther Nucleic Acids       Date:  2012-02-07       Impact factor: 10.183

View more
  132 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Disease genetics: Prion variant pathogenicity through large-scale population sequencing.

Authors:  Darren J Burgess
Journal:  Nat Rev Genet       Date:  2016-02-01       Impact factor: 53.242

Review 3.  Machine learning, the kidney, and genotype-phenotype analysis.

Authors:  Rachel S G Sealfon; Laura H Mariani; Matthias Kretzler; Olga G Troyanskaya
Journal:  Kidney Int       Date:  2020-04-01       Impact factor: 10.612

4.  The Genetic Landscape of Diamond-Blackfan Anemia.

Authors:  Jacob C Ulirsch; Jeffrey M Verboon; Shideh Kazerounian; Michael H Guo; Daniel Yuan; Leif S Ludwig; Robert E Handsaker; Nour J Abdulhay; Claudia Fiorini; Giulio Genovese; Elaine T Lim; Aaron Cheng; Beryl B Cummings; Katherine R Chao; Alan H Beggs; Casie A Genetti; Colin A Sieff; Peter E Newburger; Edyta Niewiadomska; Michal Matysiak; Adrianna Vlachos; Jeffrey M Lipton; Eva Atsidaftos; Bertil Glader; Anupama Narla; Pierre-Emmanuel Gleizes; Marie-Françoise O'Donohue; Nathalie Montel-Lehry; David J Amor; Steven A McCarroll; Anne H O'Donnell-Luria; Namrata Gupta; Stacey B Gabriel; Daniel G MacArthur; Eric S Lander; Monkol Lek; Lydie Da Costa; David G Nathan; Andrei A Korostelev; Ron Do; Vijay G Sankaran; Hanna T Gazda
Journal:  Am J Hum Genet       Date:  2018-11-29       Impact factor: 11.025

5.  Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development.

Authors:  Sonia M Vallabh; Chloe K Nobuhara; Franc Llorens; Inga Zerr; Piero Parchi; Sabina Capellari; Eric Kuhn; Jacob Klickstein; Jiri G Safar; Flavia C Nery; Kathryn J Swoboda; Michael D Geschwind; Henrik Zetterberg; Steven E Arnold; Eric Vallabh Minikel; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-01       Impact factor: 11.205

6.  Towards authentic transgenic mouse models of heritable PrP prion diseases.

Authors:  Joel C Watts; Kurt Giles; Matthew E C Bourkas; Smita Patel; Abby Oehler; Marta Gavidia; Sumita Bhardwaj; Joanne Lee; Stanley B Prusiner
Journal:  Acta Neuropathol       Date:  2016-06-28       Impact factor: 17.088

7.  Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation.

Authors:  Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve
Journal:  Neurocase       Date:  2020-06-30       Impact factor: 0.881

Review 8.  Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease.

Authors:  Allyson Connor; Han Wang; Brian S Appleby; Daniel D Rhoads
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

Review 9.  The current state of clinical interpretation of sequence variants.

Authors:  Derick C Hoskinson; Adrian M Dubuc; Heather Mason-Suares
Journal:  Curr Opin Genet Dev       Date:  2017-01-31       Impact factor: 5.578

10.  Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry.

Authors:  Eric Vallabh Minikel; Eric Kuhn; Alexandra R Cocco; Sonia M Vallabh; Christina R Hartigan; Andrew G Reidenbach; Jiri G Safar; Gregory J Raymond; Michael D McCarthy; Rhonda O'Keefe; Franc Llorens; Inga Zerr; Sabina Capellari; Piero Parchi; Stuart L Schreiber; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2019-09-26       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.